vaccine

By Colin Kellaher Moderna Inc. on Monday said the US Food and Drug Administration has granted breakthrough therapy designation to its mRNA-1345 investigational vaccine candidate for respiratory syncytial virus, or…

The key to these vaccines appears to be proteins in pancreatic tumors, called neoantigens, that alert the immune system to keep the cancer at bay. (PHOTO CREDIT: Creative Commons) Messenger RNA (mRNA) vaccines may be the…

Jan 17 (Reuters) - Moderna Inc said on Tuesday that its experimental messenger RNA vaccine for respiratory syncytial virus (RSV) was 83.7% effective in a late-stage trial in preventing at least two symptoms, such as cough and fever, in…

By Colin Kellaher Pfizer Inc. on Friday said the US Food and Drug Administration has granted priority review to its application seeking expanded approval of its Prevnar 20 vaccine for infants and children.…